1. Home
  2. TSBX vs HYZN Comparison

TSBX vs HYZN Comparison

Compare TSBX & HYZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSBX
  • HYZN
  • Stock Information
  • Founded
  • TSBX 2015
  • HYZN 2020
  • Country
  • TSBX United States
  • HYZN United States
  • Employees
  • TSBX N/A
  • HYZN N/A
  • Industry
  • TSBX
  • HYZN Construction/Ag Equipment/Trucks
  • Sector
  • TSBX
  • HYZN Consumer Discretionary
  • Exchange
  • TSBX Nasdaq
  • HYZN Nasdaq
  • Market Cap
  • TSBX 11.4M
  • HYZN 14.3M
  • IPO Year
  • TSBX 2023
  • HYZN N/A
  • Fundamental
  • Price
  • TSBX $0.48
  • HYZN $1.14
  • Analyst Decision
  • TSBX Buy
  • HYZN Strong Buy
  • Analyst Count
  • TSBX 3
  • HYZN 1
  • Target Price
  • TSBX $4.75
  • HYZN $80.00
  • AVG Volume (30 Days)
  • TSBX 90.5K
  • HYZN 207.5K
  • Earning Date
  • TSBX 11-12-2024
  • HYZN 11-13-2024
  • Dividend Yield
  • TSBX N/A
  • HYZN N/A
  • EPS Growth
  • TSBX N/A
  • HYZN N/A
  • EPS
  • TSBX N/A
  • HYZN N/A
  • Revenue
  • TSBX N/A
  • HYZN $10,725,000.00
  • Revenue This Year
  • TSBX N/A
  • HYZN $3,703.39
  • Revenue Next Year
  • TSBX N/A
  • HYZN N/A
  • P/E Ratio
  • TSBX N/A
  • HYZN N/A
  • Revenue Growth
  • TSBX N/A
  • HYZN 1262.77
  • 52 Week Low
  • TSBX $0.40
  • HYZN $0.95
  • 52 Week High
  • TSBX $5.75
  • HYZN $46.00
  • Technical
  • Relative Strength Index (RSI)
  • TSBX 39.58
  • HYZN 26.11
  • Support Level
  • TSBX $0.48
  • HYZN $1.81
  • Resistance Level
  • TSBX $0.51
  • HYZN $1.96
  • Average True Range (ATR)
  • TSBX 0.05
  • HYZN 0.14
  • MACD
  • TSBX -0.00
  • HYZN -0.04
  • Stochastic Oscillator
  • TSBX 22.22
  • HYZN 16.35

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

About HYZN Hyzon Motors Inc.

Hyzon Motors Inc assembles and supplies hydrogen fuel cell-powered commercial vehicles across North America, Europe, China, and Australasia. In addition, it builds and fosters a clean hydrogen supply ecosystem with partners from feedstocks through production, dispensing and financing. The company intends to meet its customers' zero-emission vehicle needs by electrifying proven vehicle platforms utilizing its industry- leading fuel cell and electric propulsion technologies. It expects to deploy these technologies in various vehicle classes, including heavy-duty and medium-duty trucks and buses with the potential for future expansion into light-duty commercial vehicles, additional mobility use cases and stationary power applications.

Share on Social Networks: